Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 35 member B2 (SLC35B2) is a transporter protein located in the Golgi and endoplasmic reticulum membranes that mediates the import of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), the universal sulfuryl donor, from the cytosol into the Golgi lumen. This process is essential for the sulfation of glycans, glycoproteins, and glycolipids—a key modification affecting protein and extracellular matrix function. Loss-of-function mutations in SLC35B2 cause inherited disorders of sulfation such as hypomyelinating leukodystrophy and skeletal dysplasia. SLC35B2 is also required for the correct sulfation of cell-surface heparan sulfate proteoglycans, which regulate cellular recognition, viral entry, and growth factor signaling. There are no approved drugs directly targeting SLC35B2, and broad inhibition raises safety concerns due to the global impact on sulfation pathways.
Inhibition or loss-of-function would reduce cellular sulfation by impairing PAPS transport into the Golgi, affecting the synthesis of sulfated proteins and glycosaminoglycans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member B2 (SLC35B2).